Three-D is all the buzz, as PACS companies struggle to include it in their products, if they haven’t already. But where this form of advanced visualization fits into the diagnostic process is still up in the air. Ironically, so are some of the everyday tools on which advanced visualization depends. Trust issues about the automation that makes sophisticated postprocessing viable are beginning to surface, just as progress in CAD offers new clinical capabilities.
Three-D is all the buzz, as PACS companies struggle to include it in their products, if they haven’t already. But where this form of advanced visualization fits into the diagnostic process is still up in the air. Ironically, so are some of the everyday tools on which advanced visualization depends. Trust issues about the automation that makes sophisticated postprocessing viable are beginning to surface, just as progress in CAD offers new clinical capabilities.
On Wednesday, May 19, Dr. Jeffrey Mendel, an assistant professor of radiology at Tufts University, will argue in favor of routinely reading studies in 3D. Doing so improves confidence and speeds interpretations of neuro images. It also helps localize masses just about anywhere, according to Mendel. Making 3D part of the routine will be discussed in terms of a broader PACS strategy that involves not only interpretation but access, distribution, and archiving of the data.
Dr. Jacob Sosna, section chief for CT at Hadassah-Hebrew University Medical Center in Jerusalem, will examine the absence of tools for evaluating the precision of segmentation algorithms, which are increasingly being adopted. The significance of not being able to compare the performance of these algorithms will grow as the community becomes ever more dependent on them. Sosna will demonstrate, however, that the algorithms can be compared, illustrating this with data generated using algorithms that grade automated carotid bifurcation lumen segmentation and stenosis.
Laura J. Pierce, 3D Lab Manager at Stanford Radiology, will speak on the role of quality control programs in 3D imaging, noting the operator dependence of 3D and how missteps can lead to anatomical misrepresentations, as well as delayed or inappropriately altered patient treatment. Among the sources of error are data entry, incorrect segmentation, and annotation. Pierce will explain how the types of errors must first be recognized, including types of errors in postprocessing, PACS workflow, and measurement, and how, once the causes of errors are documented, these errors might be prevented.
The promise of CAD for pulmonary embolism identification has been one of the great unrealized potentials of CT. Dr. Charles White, director of thoracic imaging in the University of Maryland radiology department, will look at how thin-slice data and advances in CAD technology have set the stage for advances in PE CAD, presenting data demonstrating its promise as a stand-alone tool and as a second reader.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.